• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制免疫治疗潜力:空间转录组学在揭示头颈部鳞状细胞癌肿瘤免疫微环境中的应用

Mapping immunotherapy potential: spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma.

作者信息

Choi Seo-Won, Kim Jeong Heon, Hong Jisu, Kwon Minsu

机构信息

Department of Otolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Front Immunol. 2025 Apr 8;16:1568590. doi: 10.3389/fimmu.2025.1568590. eCollection 2025.

DOI:10.3389/fimmu.2025.1568590
PMID:40264779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12011851/
Abstract

Head and neck squamous cell carcinoma (HNSCC) often exhibits poor response rates to immune checkpoint inhibitor (ICI) therapies, largely owing to the intricate composition and spatial organization of immune cells within the tumor-immune microenvironment (TIME). The diversity of immune cell populations, their spatial relationships, and dynamic interactions significantly influence the immunosuppressive nature of the TIME, thereby limiting the efficacy of immunotherapy. To address these challenges and enhance the therapeutic potential of ICIs in HNSCC, a comprehensive analysis of the TIME is essential. Spatial transcriptomics (ST), a cutting-edge technology, enables high-resolution mapping of gene expression within the spatial context of the tumor, providing critical insights into the functional roles and interactions of immune cells in the TIME. This review highlights the importance of ST in uncovering the complexities of the TIME in HNSCC and proposes strategies for leveraging these insights to develop more effective immunotherapeutic approaches. By integrating spatial and molecular information, this review aims to pave the way for personalized and precision-based treatments in HNSCC, ultimately improving patient outcomes.

摘要

头颈部鳞状细胞癌(HNSCC)对免疫检查点抑制剂(ICI)疗法的反应率往往较低,这在很大程度上归因于肿瘤免疫微环境(TIME)中免疫细胞复杂的组成和空间组织。免疫细胞群体的多样性、它们的空间关系以及动态相互作用显著影响了TIME的免疫抑制特性,从而限制了免疫治疗的效果。为应对这些挑战并增强ICI在HNSCC中的治疗潜力,对TIME进行全面分析至关重要。空间转录组学(ST)作为一项前沿技术,能够在肿瘤的空间背景下对基因表达进行高分辨率定位,为深入了解TIME中免疫细胞的功能作用和相互作用提供关键见解。本综述强调了ST在揭示HNSCC中TIME复杂性方面的重要性,并提出了利用这些见解开发更有效免疫治疗方法的策略。通过整合空间和分子信息,本综述旨在为HNSCC的个性化和精准治疗铺平道路,最终改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b28/12011851/d0e9096df718/fimmu-16-1568590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b28/12011851/241808273271/fimmu-16-1568590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b28/12011851/d0e9096df718/fimmu-16-1568590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b28/12011851/241808273271/fimmu-16-1568590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b28/12011851/d0e9096df718/fimmu-16-1568590-g002.jpg

相似文献

1
Mapping immunotherapy potential: spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma.绘制免疫治疗潜力:空间转录组学在揭示头颈部鳞状细胞癌肿瘤免疫微环境中的应用
Front Immunol. 2025 Apr 8;16:1568590. doi: 10.3389/fimmu.2025.1568590. eCollection 2025.
2
Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response.头颈部癌中PD-1/PD-L1的空间相互作用图谱揭示了与免疫治疗反应相关的巨噬细胞-肿瘤屏障的作用。
J Transl Med. 2025 Feb 12;23(1):177. doi: 10.1186/s12967-025-06186-y.
3
Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma.空间转录组学揭示下咽鳞癌肿瘤微环境和 SLCO2A1 与肿瘤抑制相关。
Int Immunopharmacol. 2024 Dec 5;142(Pt B):113243. doi: 10.1016/j.intimp.2024.113243. Epub 2024 Sep 27.
4
Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma.整合免疫多组学和机器学习以改善头颈部鳞状细胞癌的预后、免疫格局以及对一线和二线治疗的敏感性。
Sci Rep. 2024 Dec 28;14(1):31454. doi: 10.1038/s41598-024-83184-y.
5
TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma.TP63 通过转录调控 SLC7A5 抑制头颈部鳞状细胞癌中的铁死亡。
Front Immunol. 2024 Aug 21;15:1445472. doi: 10.3389/fimmu.2024.1445472. eCollection 2024.
6
Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy.整合多组学揭示乳酸代谢相关基因特征及糖原磷酸化酶在预测头颈部鳞状细胞癌预后和免疫治疗疗效中的作用。
BMC Cancer. 2025 Apr 24;25(1):773. doi: 10.1186/s12885-025-13982-8.
7
Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors.PNCK 抑制可使肿瘤微环境发炎,并使头颈部鳞状细胞癌对免疫检查点抑制剂敏感。
J Immunother Cancer. 2024 Oct 12;12(10):e009893. doi: 10.1136/jitc-2024-009893.
8
Integrative single cell transcriptomic analysis reveals 3p deletion associated tumor microenvironment and chemoresistance in head and neck squamous cell carcinoma.综合单细胞转录组分析揭示头颈部鳞状细胞癌中与3p缺失相关的肿瘤微环境和化疗耐药性。
Sci Rep. 2025 Mar 10;15(1):8224. doi: 10.1038/s41598-025-92078-6.
9
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.全面描绘肿瘤微环境,评估头颈部鳞状细胞癌患者的免疫治疗效果。
Aging (Albany NY). 2020 Nov 18;12(22):22509-22526. doi: 10.18632/aging.103460.
10
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response.头颈部癌症中三级淋巴滤泡的空间动态:免疫治疗反应的见解。
J Transl Med. 2024 Jul 24;22(1):677. doi: 10.1186/s12967-024-05409-y.

本文引用的文献

1
Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma.空间转录组学揭示下咽鳞癌肿瘤微环境和 SLCO2A1 与肿瘤抑制相关。
Int Immunopharmacol. 2024 Dec 5;142(Pt B):113243. doi: 10.1016/j.intimp.2024.113243. Epub 2024 Sep 27.
2
Single-cell and Spatial Transcriptomic Analyses Implicate Formation of the Immunosuppressive Microenvironment during Breast Tumor Progression.单细胞和空间转录组分析表明,免疫抑制微环境在乳腺癌进展过程中的形成。
J Immunol. 2024 Nov 1;213(9):1392-1401. doi: 10.4049/jimmunol.2400025.
3
Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis.
重新分析单细胞和空间转录组学数据揭示了胃癌微环境中的 B 细胞景观及其与肿瘤细胞的潜在相互作用,以预测临床预后。
J Transl Med. 2024 Aug 30;22(1):807. doi: 10.1186/s12967-024-05606-9.
4
Tertiary lymphoid structures in anticancer immunity.肿瘤免疫中的三级淋巴结构
Nat Rev Cancer. 2024 Sep;24(9):629-646. doi: 10.1038/s41568-024-00728-0. Epub 2024 Aug 8.
5
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies.炎症性、排除性或无反应性免疫表型中的肿瘤微环境:机制与策略
Exp Hematol Oncol. 2024 Aug 6;13(1):80. doi: 10.1186/s40164-024-00543-1.
6
Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq.单细胞 RNA 测序高亮显示头颈部鳞状细胞癌肿瘤生态系统的免疫特征以及 Tfh 和 Th17 细胞浸润的预后价值。
Cancer Immunol Immunother. 2024 Aug 2;73(10):187. doi: 10.1007/s00262-024-03767-6.
7
Spatial landscapes of cancers: insights and opportunities.癌症的空间格局:见解与机遇
Nat Rev Clin Oncol. 2024 Sep;21(9):660-674. doi: 10.1038/s41571-024-00926-7. Epub 2024 Jul 23.
8
Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer.单细胞RNA测序联合空间转录组学在胰腺癌肿瘤微环境及治疗中的研究进展
J Transl Med. 2024 Jun 12;22(1):563. doi: 10.1186/s12967-024-05307-3.
9
Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial.雷莫芦单抗联合帕博利珠单抗治疗复发性或转移性头颈部鳞状细胞癌:一项单中心、1/2 期试验。
Lancet Oncol. 2024 Jul;25(7):888-900. doi: 10.1016/S1470-2045(24)00204-3. Epub 2024 Jun 5.
10
Single-cell and spatial transcriptomics analysis of non-small cell lung cancer.单细胞和空间转录组学分析非小细胞肺癌。
Nat Commun. 2024 May 23;15(1):4388. doi: 10.1038/s41467-024-48700-8.